cardiac resynchronisation therapy

R&D

Increasingly, electrophysiologists are exploring approaches that activate the heart through its intrinsic conduction pathways.

News

Shares in Vaxcyte have rocketed on phase 3 trial data for its pneumococcal vaccine VAX-31 that suggests it could take on rivals from Pfizer and MSD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.